Results 141 to 150 of about 61,347 (320)

Tegaserod significantly improves esophageal mechanical pain threshold, regurgitation, and global preference vs. placebo in patients with functional heartburn [PDF]

open access: bronze, 2004
Sheila Rodriguez-Stanley   +5 more
openalex   +1 more source

Amyloidosis for the Gastroenterologist: A Comprehensive Systematic Review of Diagnosis and Management of Gastrointestinal Manifestations

open access: yesJournal of Gastroenterology and Hepatology, Volume 40, Issue 12, Page 2842-2856, December 2025.
ABSTRACT Background Amyloidosis is a rare, multisystem disorder characterized by extracellular deposition of misfolded protein fibrils. Gastrointestinal (GI) amyloidosis is uncommon but under‐recognized due to nonspecific symptoms, but early diagnosis is critical to improve quality of life and prognosis.
Myo Jin Tang   +3 more
wiley   +1 more source

Some issues of the diagnosis and treatment of gastroesophageal reflux disease

open access: yesТерапевтический архив, 2015
The clinical inefficacy of proton pump inhibitors (PPIs) is very frequently encountered in nonerosive gastroesophageal reflux disease (NERD) in particular. Postprandial acid pocket, weak-acid or alkaline reflux, etc.
V G Avdeev
doaj  

Novel Application of Oral Postbiotics for Skin Condition in Healthy Middle‐Aged Women: A Randomized, Double‐Blind, and Placebo‐Controlled Study

open access: yesJournal of Cosmetic Dermatology, Volume 24, Issue 12, December 2025.
ABSTRACT Background and Purpose Latilactobacillus sakei KABP‐065 derived from pickled vegetables of East Asia can improve skin condition in patients with atopic dermatitis through a mechanism that suppresses immune hyperactivity. Here we investigated whether KABP‐065 postbiotics can improve the facial skin condition of healthy middle‐aged women ...
Jinko Sawashita   +5 more
wiley   +1 more source

The psychogenesis of peptic ulcer [PDF]

open access: yes, 1944
Thesis (M.D.)--Boston ...
Rodman, Melvin H.
core  

Efficacy and Safety of the Enterosorbent Silicolgel in Irritable Bowel Syndrome, IBS‐D and IBS‐M: A Randomized, Double‐Blind, Placebo‐Controlled, Multi‐Center Trial

open access: yesNeurogastroenterology &Motility, Volume 37, Issue 12, December 2025.
Current treatments often fall short in managing IBS effectively. Silicolgel, an enterosorbent, reduced IBS and other gastrointestinal symptoms in 90% of IBS patients compared to 20% in those on placebo. Enterosorbents are not currently recommended for IBS; silicolgel is a widely available, affordable option for patients with IBS‐D and IBS‐M.
O. Kuzminska   +3 more
wiley   +1 more source

Synchronous primary papillary breast cancer, medullary thyroid carcinoma and neuroendocrine tumor in postmenopausal woman. [PDF]

open access: yes, 2016
Multiple endocrine neoplasia are syndromes involving two or more endocrine tissues, often correlated to RET proto-oncogene mutations. We herein present the first reported case of a 57-years-old woman with three synchronous primary cancers of breast ...
DE IULIIS, Francesca   +7 more
core  

Clinical Characteristics and Outcomes of Rome IV Diarrhea‐Predominant Irritable Bowel Syndrome and Functional Diarrhea Prescribed With Ondansetron: A Real‐World Study

open access: yesNeurogastroenterology &Motility, Volume 37, Issue 12, December 2025.
In a cohort of 92 patients with chronic diarrhea (irritable bowel syndrome diarrhea predominant and functional diarrhea), nearly 74% of patients reported an improvement in their symptoms with ondansetron. Symptom relief was maintained long‐term with a low‐dose therapy.
Caterina Sbarigia   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy